These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7662854)

  • 1. Effects of heteroscedasticity upon certain analyses when regression lines are not parallel.
    Larholt KM; Sampson AR
    Biometrics; 1995 Jun; 51(2):731-7. PubMed ID: 7662854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
    Henry DH
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):12-6. PubMed ID: 8153671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous confidence bands for nonlinear regression models with application to population pharmacokinetic analyses.
    Gsteiger S; Bretz F; Liu W
    J Biopharm Stat; 2011 Jul; 21(4):708-25. PubMed ID: 21516565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of covariance in the mixed model: higher-level, nonhomogeneous, and random regressions.
    Henderson CR
    Biometrics; 1982 Sep; 38(3):623-40. PubMed ID: 7171692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Desai J; Demetri GD
    Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression analysis with missing covariate data using estimating equations.
    Zhao LP; Lipsitz S; Lew D
    Biometrics; 1996 Dec; 52(4):1165-82. PubMed ID: 8962448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On plotting renovated samples.
    Smith PJ
    Biometrics; 1995 Sep; 51(3):1147-51. PubMed ID: 7548698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.
    Cazzola M; Ponchio L; Pedrotti C; Farina G; Cerani P; Lucotti C; Novella A; Rovati A; Bergamaschi G; Beguin Y
    Haematologica; 1996; 81(5):434-41. PubMed ID: 8952157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response models with covariates.
    Wijesinha MC; Piantadosi S
    Biometrics; 1995 Sep; 51(3):977-87. PubMed ID: 7548713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence intervals for median survival times under a piecewise exponential model with proportional hazards covariate effects.
    Karrison T
    Stat Med; 1996 Jan; 15(2):171-82. PubMed ID: 8614753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.